Devon Stonerock, PharmD, BCOP retweetledi

Presented at #EHA2025:
Among patients undergoing stem-cell transplantation from matched related donors, cyclophosphamide plus cyclosporin led to significantly longer GVHD-free, relapse-free survival than standard prophylaxis. Full ALLG BM12 CAST phase 3 trial results: nej.md/3Zpri7z
@eha_hematology

English























